Login

Irvine industrial property trades again as owner-user outbids redevelopment plans

Robinson Pharma pays premium in one of the California area’s priciest deals
Exterior of the industrial property at 2323 Main St. in Irvine, which Robinson Pharma acquired for $75 million in one of Orange County’s largest industrial sales of the year. The deal underscores growing demand from companies seeking to own and occupy their facilities. (CoStar)
Exterior of the industrial property at 2323 Main St. in Irvine, which Robinson Pharma acquired for $75 million in one of Orange County’s largest industrial sales of the year. The deal underscores growing demand from companies seeking to own and occupy their facilities. (CoStar)
CoStar News
August 25, 2026 | 11:30 P.M.

Robinson Pharma paid about $75 million for an Irvine industrial building, scuttling plans to redevelop the site into housing less than three months after investors acquired it for $52 million.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In

IN THIS ARTICLE